WallStreetZenWallStreetZen

NASDAQ: SGMO
Sangamo Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SGMO

Based on 6 analysts offering 12 month price targets for Sangamo Therapeutics Inc

Min Forecast
$2.00+159.07%
Avg Forecast
$5.17+569.3%
Max Forecast
$10.00+1,195.34%

Should I buy or sell SGMO stock?

Based on 6 analysts offering ratings for Sangamo Therapeutics Inc.

Buy
Strong Buy
3 analysts 50%
Buy
1 analysts 16.67%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SGMO's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SGMO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SGMO stock forecasts and price targets.

SGMO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-07
lockedlocked$00.00+00.00%2025-03-18
lockedlocked$00.00+00.00%2025-01-23
lockedlocked$00.00+00.00%2024-12-31
lockedlocked$00.00+00.00%2024-12-31
Barclays
Bottom 5%
5
Strong BuyMaintains$9.00+1,065.80%2024-11-14

1 of 1

Forecast return on equity

Is SGMO forecast to generate an efficient return?

Company
-75.69%
Industry
142.9%
Market
80.27%
SGMO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SGMO forecast to generate an efficient return on assets?

Company
-16.96%
Industry
35.65%
SGMO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SGMO earnings per share forecast

What is SGMO's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.39
Avg 2 year Forecast
-$0.35
Avg 3 year Forecast
-$0.23

SGMO revenue forecast

What is SGMO's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$47.0M-18.74%
Avg 2 year Forecast
$45.6M-21.17%
Avg 3 year Forecast
$95.5M+65.17%
SGMO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SGMO revenue growth forecast

How is SGMO forecast to perform vs Biotechnology companies and vs the US market?

Company
14.57%
Industry
64.17%
Market
10.07%
SGMO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SGMO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SGMO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SGMO$0.77$5.17+569.30%Buy
ACIU$1.73$16.00+824.86%Buy
SLN$3.70$40.80+1,002.70%Buy
PRQR$1.66$8.00+381.93%Strong Buy
LRMR$2.65$17.50+560.38%Strong Buy
View Top Biotech Stocks

Sangamo Therapeutics Stock Forecast FAQ

Is Sangamo Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: SGMO) stock is to Buy SGMO stock.

Out of 6 analysts, 3 (50%) are recommending SGMO as a Strong Buy, 1 (16.67%) are recommending SGMO as a Buy, 2 (33.33%) are recommending SGMO as a Hold, 0 (0%) are recommending SGMO as a Sell, and 0 (0%) are recommending SGMO as a Strong Sell.

If you're new to stock investing, here's how to buy Sangamo Therapeutics stock.

What is SGMO's earnings growth forecast for 2025-2027?

(NASDAQ: SGMO) Sangamo Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.

Sangamo Therapeutics's earnings in 2025 is -$97,941,000.On average, 4 Wall Street analysts forecast SGMO's earnings for 2025 to be -$86,513,357, with the lowest SGMO earnings forecast at -$123,590,510, and the highest SGMO earnings forecast at -$26,965,202. On average, 4 Wall Street analysts forecast SGMO's earnings for 2026 to be -$78,086,732, with the lowest SGMO earnings forecast at -$98,872,408, and the highest SGMO earnings forecast at -$47,189,104.

In 2027, SGMO is forecast to generate -$50,941,761 in earnings, with the lowest earnings forecast at -$87,636,907 and the highest earnings forecast at -$11,235,501.

What is SGMO's revenue growth forecast for 2025-2027?

(NASDAQ: SGMO) Sangamo Therapeutics's forecast annual revenue growth rate of 14.57% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.07%.

Sangamo Therapeutics's revenue in 2025 is $57,800,000.On average, 3 Wall Street analysts forecast SGMO's revenue for 2025 to be $10,553,730,752, with the lowest SGMO revenue forecast at $3,348,179,283, and the highest SGMO revenue forecast at $24,268,682,052. On average, 3 Wall Street analysts forecast SGMO's revenue for 2026 to be $10,239,136,726, with the lowest SGMO revenue forecast at $2,224,629,188, and the highest SGMO revenue forecast at $19,954,249,687.

In 2027, SGMO is forecast to generate $21,452,166,674 in revenue, with the lowest revenue forecast at $11,684,920,988 and the highest revenue forecast at $36,762,559,108.

What is SGMO's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SGMO) forecast ROA is -16.96%, which is lower than the forecast US Biotechnology industry average of 35.65%.

What is SGMO's Price Target?

According to 6 Wall Street analysts that have issued a 1 year SGMO price target, the average SGMO price target is $5.17, with the highest SGMO stock price forecast at $10.00 and the lowest SGMO stock price forecast at $2.00.

On average, Wall Street analysts predict that Sangamo Therapeutics's share price could reach $5.17 by Apr 7, 2026. The average Sangamo Therapeutics stock price prediction forecasts a potential upside of 569.3% from the current SGMO share price of $0.77.

What is SGMO's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SGMO) Sangamo Therapeutics's current Earnings Per Share (EPS) is -$0.49. On average, analysts forecast that SGMO's EPS will be -$0.39 for 2025, with the lowest EPS forecast at -$0.55, and the highest EPS forecast at -$0.12. On average, analysts forecast that SGMO's EPS will be -$0.35 for 2026, with the lowest EPS forecast at -$0.44, and the highest EPS forecast at -$0.21. In 2027, SGMO's EPS is forecast to hit -$0.23 (min: -$0.39, max: -$0.05).

What is SGMO's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SGMO) forecast ROE is -75.69%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.